Kobuch, Sophie
Tsang, Fiona
Chimoriya, Ritesh
Gossayn, Daniel
O’Brien, Sarah
Jamal, Javeria
Laks, Leon
Tahrani, Abd
Kormas, Nic
Piya, Milan K
Funding for this research was provided by:
Western Sydney University, Australia (Internal Departmental Funds)
Article History
Received: 22 September 2021
Accepted: 19 October 2021
First Online: 14 November 2021
Declarations
:
: All methods were performed in accordance with the Declaration of Helsinki, and this study was approved by the South Western Sydney Local Health District (SWSLHD) Research Ethics Committee as a quality assurance project (Reference: CT22_2018).
: Not applicable.
: The authors have no conflict of interest to declare, apart from Dr Tahrani (AAT) who reports the following outside the submitted work. Grants from Novo Nordisk and Sanofi; personal fees from Novo Nordisk, Janssen, AZ, Eli Lilly, BI, BMS, NAPP, MSD, Nestle, Gilead, Sanofi; as well as non-financial support from Novo Nordisk, Eli Lilly, AZ, Impeto medical, Resmed, Aptiva, BI, BMS, NAPP, MSD. AAT is currently an employee of Novo Nordisk but this work was performed before he became a Novo Nordisk employee.